Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioXcel and Takeda Partner | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioXcel and Takeda Partner

Will repurpose assets for orphan diseases

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioXcel Corporation, a provider of cloud-based Pharma big data solutions for discovering novel products, has entered into a partnership with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases. Through this partnership, Takeda, a global research-based company with a focus on innovation in medicine, will gain access to and leverage BioXcel’s Big Data Innovation Lab, an integrated product discovery engine, and PharmGPS Orphan Disease Suite for drug discovery and repurposing.

Commenting on the partnership, BioXcel’s chief executive officer and chairman, Vimal Mehta, said, “We are pleased that Takeda will leverage our expertise in rare and ultra rare diseases to support their innovation and portfolio expansion initiatives. Discovering novel applications for existing molecules is an increasingly attractive strategy to address patient needs, while capitalizing on previous investments and de-risking clinical development. Our Big Data Innovation Lab facilitates the repurposing of the most attractive candidates applicable to a given disease.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics